PGR
65
2
SYY
53
4
GPC
40
3
ZION
65
2
PBI
69
4
CRM
67
2
NEE
50
-5
DE
63
3
RSG
71
3
ILMN
42
5
CTSH
56
2
EQT
57
-2
PSX
47
2
AAP
24
6
PPL
54
-5
AIV
72
2
EQIX
64
2
DG
6
2
LB
63
22
BAC
53
3
PGR
65
2
SYY
53
4
GPC
40
3
ZION
65
2
PBI
69
4
CRM
67
2
NEE
50
-5
DE
63
3
RSG
71
3
ILMN
42
5
CTSH
56
2
EQT
57
-2
PSX
47
2
AAP
24
6
PPL
54
-5
AIV
72
2
EQIX
64
2
DG
6
2
LB
63
22
BAC
53
3
Financhill
Back

NeuroBo Pharmaceuticals Vs. ZyVersa Therapeutics Industry Stock Comparison

Sell
22

NRBO
NeuroBo Pharmaceuticals

Last Price:
2.40
Seasonality Move:
6.18%
Sell
8

ZVSA
ZyVersa Therapeutics

Last Price:
1.12
Seasonality Move:
-78.1%
Sell
22
NeuroBo Pharmaceuticals (NRBO) is a Sell

Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?

  • The current NeuroBo Pharmaceuticals [NRBO] share price is $2.37. The Score for NRBO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
ZyVersa Therapeutics (ZVSA) is a Sell

Is ZyVersa Therapeutics a Buy, Sell or Hold?

  • The current ZyVersa Therapeutics [ZVSA] share price is $1.13. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NRBO Stock Price Chart

What is NeuroBo Pharmaceuticals's stock price today?

  • The NeuroBo Pharmaceuticals share price today is $2.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.

ZVSA Stock Price Chart

What is ZyVersa Therapeutics's stock price today?

  • The ZyVersa Therapeutics share price today is $1.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NRBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 40.38 Sell
Chaikin Money Flow: -15734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.81) Sell
Bollinger Bands (100): (2.68 - 4.12) Sell

ZVSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 32.04 Sell
Chaikin Money Flow: 123461 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 2.11) Sell
Bollinger Bands (100): (1.74 - 3.62) Sell

NRBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.38 Sell
20-day SMA: 2.56 Sell
50-day SMA: 2.81 Sell
200-day SMA: 3.85 Sell
8-day EMA: 2.41 Sell
20-day EMA: 2.53 Sell
50-day EMA: 2.82 Sell
200-day EMA: 4.7 Sell

ZVSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.17 Sell
20-day SMA: 1.54 Sell
50-day SMA: 1.98 Sell
200-day SMA: 4.44 Sell
8-day EMA: 1.22 Sell
20-day EMA: 1.48 Sell
50-day EMA: 1.96 Sell
200-day EMA: 41.76 Sell

NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ZyVersa Therapeutics Earnings Growth & ZVSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.

NeuroBo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ZyVersa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):